Product: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Reason for recall: cGMP deviations.
Recall initiated: 20260401
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated